# FDA Inspection 1253398 - Takeda Pharmaceuticals USA - October 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa/c970fdae-8e8f-4ce7-941e-5d21130ba3ab
Source feed: FDA_Inspections

> FDA Inspection 1253398 for Takeda Pharmaceuticals USA on October 16, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253398
- Company Name: Takeda Pharmaceuticals USA
- Inspection Date: 2024-10-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1253398 - 2024-10-16](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa/b1ebc5df-04fc-4f0b-917e-ed949c1f6697)
- [FDA Inspection 1231407 - 2024-03-22](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa/b7cf67ce-f814-45fc-9e0c-7142df86208d)

Company: https://www.keypedia.com/companies/takeda-pharmaceuticals-usa/2cc60460-dde7-47a7-968e-c06ce6a85515

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c